annual retained earnings:
$285.16M+$163.89M(+135.14%)Summary
- As of today (July 1, 2025), CPRX annual retained earnings is $285.16 million, with the most recent change of +$163.89 million (+135.14%) on December 31, 2024.
- During the last 3 years, CPRX annual retained earnings has risen by +$311.47 million (+1183.85%).
- CPRX annual retained earnings is now at all-time high.
Performance
CPRX Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
$341.90M+$56.74M(+19.90%)Summary
- As of today (July 1, 2025), CPRX quarterly retained earnings is $341.90 million, with the most recent change of +$56.74 million (+19.90%) on March 31, 2025.
- Over the past year, CPRX quarterly retained earnings has increased by +$197.35 million (+136.53%).
- CPRX quarterly retained earnings is now at all-time high.
Performance
CPRX quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CPRX Retained earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +135.1% | +136.5% |
3 y3 years | +1183.8% | +2288.8% |
5 y5 years | +321.6% | +389.1% |
CPRX Retained earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1183.8% | at high | >+9999.0% |
5 y | 5-year | at high | +321.6% | at high | +415.2% |
alltime | all time | at high | +277.6% | at high | +312.1% |
CPRX Retained earnings History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $341.90M(+19.9%) |
Dec 2024 | $285.16M(+135.1%) | $285.16M(+24.4%) |
Sep 2024 | - | $229.22M(+23.7%) |
Jun 2024 | - | $185.34M(+28.2%) |
Mar 2024 | - | $144.55M(+19.2%) |
Dec 2023 | $121.27M(+143.2%) | $121.27M(+40.3%) |
Sep 2023 | - | $86.43M(-26.3%) |
Jun 2023 | - | $117.19M(+47.5%) |
Mar 2023 | - | $79.43M(+59.3%) |
Dec 2022 | $49.86M(-289.5%) | $49.86M(+104.4%) |
Sep 2022 | - | $24.39M(+1384.5%) |
Jun 2022 | - | $1.64M(-110.5%) |
Mar 2022 | - | -$15.62M(-40.6%) |
Dec 2021 | -$26.31M(-51.0%) | -$26.31M(-19.2%) |
Sep 2021 | - | -$32.54M(-14.0%) |
Jun 2021 | - | -$37.82M(-18.4%) |
Mar 2021 | - | -$46.34M(-13.7%) |
Dec 2020 | -$53.70M(-58.3%) | -$53.70M(-17.6%) |
Sep 2020 | - | -$65.14M(-40.0%) |
Jun 2020 | - | -$108.48M(-8.3%) |
Mar 2020 | - | -$118.26M(-8.1%) |
Dec 2019 | -$128.69M(-19.9%) | -$128.69M(-5.8%) |
Sep 2019 | - | -$136.62M(-9.1%) |
Jun 2019 | - | -$150.25M(-6.8%) |
Mar 2019 | - | -$161.21M(+0.4%) |
Dec 2018 | -$160.56M(+26.9%) | -$160.56M(+9.9%) |
Sep 2018 | - | -$146.06M(+5.7%) |
Jun 2018 | - | -$138.23M(+4.5%) |
Mar 2018 | - | -$132.26M(+4.5%) |
Dec 2017 | -$126.56M(+17.0%) | -$126.56M(+4.4%) |
Sep 2017 | - | -$121.17M(+3.6%) |
Jun 2017 | - | -$117.00M(+3.4%) |
Mar 2017 | - | -$113.12M(+4.6%) |
Dec 2016 | -$108.15M(+20.1%) | -$108.15M(+4.0%) |
Sep 2016 | - | -$103.98M(+4.0%) |
Jun 2016 | - | -$100.03M(+4.8%) |
Mar 2016 | - | -$95.46M(+6.0%) |
Dec 2015 | -$90.08M | -$90.08M(+6.9%) |
Sep 2015 | - | -$84.26M(+5.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | -$79.81M(+6.1%) |
Mar 2015 | - | -$75.25M(+7.7%) |
Dec 2014 | -$69.84M(+28.5%) | -$69.84M(+5.3%) |
Sep 2014 | - | -$66.35M(+8.2%) |
Jun 2014 | - | -$61.34M(+5.5%) |
Mar 2014 | - | -$58.14M(+7.0%) |
Dec 2013 | -$54.33M(+28.8%) | -$54.33M(+2.6%) |
Sep 2013 | - | -$52.98M(+12.6%) |
Jun 2013 | - | -$47.07M(+7.2%) |
Mar 2013 | - | -$43.92M(+4.1%) |
Dec 2012 | -$42.18M(+10.7%) | -$42.18M(+0.2%) |
Sep 2012 | - | -$42.10M(+6.6%) |
Jun 2012 | - | -$39.48M(+0.7%) |
Mar 2012 | - | -$39.19M(+2.9%) |
Dec 2011 | -$38.10M(+20.2%) | -$38.10M(+6.6%) |
Sep 2011 | - | -$35.75M(+3.3%) |
Jun 2011 | - | -$34.62M(+4.2%) |
Mar 2011 | - | -$33.23M(+4.8%) |
Dec 2010 | -$31.71M(+14.5%) | -$31.71M(+2.4%) |
Sep 2010 | - | -$30.98M(+3.0%) |
Jun 2010 | - | -$30.08M(+4.6%) |
Mar 2010 | - | -$28.75M(+3.8%) |
Dec 2009 | -$27.71M(+35.4%) | -$27.71M(+4.4%) |
Sep 2009 | - | -$26.54M(+5.1%) |
Jun 2009 | - | -$25.26M(+7.5%) |
Mar 2009 | - | -$23.49M(+14.8%) |
Dec 2008 | -$20.46M(+106.7%) | -$20.46M(+22.4%) |
Sep 2008 | - | -$16.72M(+20.6%) |
Jun 2008 | - | -$13.86M(+20.7%) |
Mar 2008 | - | -$11.48M(+16.0%) |
Dec 2007 | -$9.90M(+71.9%) | -$9.90M(+10.6%) |
Sep 2007 | - | -$8.95M(+8.9%) |
Jun 2007 | - | -$8.22M(+17.2%) |
Mar 2007 | - | -$7.01M(+21.7%) |
Dec 2006 | -$5.76M(+90.1%) | -$5.76M(+14.8%) |
Sep 2006 | - | -$5.02M(+35.7%) |
Jun 2006 | - | -$3.70M(+22.0%) |
Dec 2005 | -$3.03M(+147.5%) | -$3.03M(+147.5%) |
Dec 2004 | -$1.22M | -$1.22M |
FAQ
- What is Catalyst Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual retained earnings year-on-year change?
- What is Catalyst Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly retained earnings year-on-year change?
What is Catalyst Pharmaceuticals annual retained earnings?
The current annual retained earnings of CPRX is $285.16M
What is the all time high annual retained earnings for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual retained earnings is $285.16M
What is Catalyst Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, CPRX annual retained earnings has changed by +$163.89M (+135.14%)
What is Catalyst Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CPRX is $341.90M
What is the all time high quarterly retained earnings for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly retained earnings is $341.90M
What is Catalyst Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, CPRX quarterly retained earnings has changed by +$197.35M (+136.53%)